The U.S. Court of Appeals for the Eleventh Circuit unanimously affirmed the grant of summary judgment to client, Novartis Pharmaceuticals in Rider/Siharath v. Sandoz Pharm. Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). This decision…
In March 2000, the U.S. District Court for the Western District of Oklahoma entered summary judgment for firm client Sandoz Pharmaceuticals Corp., holding that the plaintiff’s proffered expert testimony that Parlodel caused her stroke was not…
Following a two-day evidentiary Daubert hearing in Caraker v. Sandoz Pharm. Corp., 172 F. Supp. 2d 1046 (S.D. Ill. 2001), Judge J. Phil Gilbert granted Firm client Sandoz’s motion to exclude expert testimony of plaintiffs’ expert witnesses…
In a unanimous decision, the 8th Circuit affirmed the grant of summary judgment to Novartis in Glastetter v. Novartis Pharmaceuticals Corp., 252 F.3d 986 (8th Cir. 2001). This significant Daubert decision and the decision below have…
March 19, 2001 by Emily Heller For litigators who defend, winning summary judgment is about as good as it gets. To many, it’s even more satisfying than a favorable jury verdict because it avoids the expense…
The U.S. District Court for the Northern District of Georgia issued a 69-page Daubert opinion in favor of our client in Rider/Siharath v. Sandoz Pharmaceuticals Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). Among the…
